Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
Gang Wang,1 Xiumin You,2 Xueyi Wang,3 Xiufeng Xu,4 Ludong Bai,5 Jian Xie,6 Zhijian Yao,7 QiZhong Yi,8 Jun Ma,9 Jinan Wang,10 Jianmin Zhuo,11 Cuili Hu11 1Psychiatry Department, Beijing Anding Hospital, Capital Medical University, National Clinical Research Center for Mental Disorders, Beijing, China...
Saved in:
Main Authors: | Wang G, You X, Wang X, Xu X, Bai L, Xie J, Yao Z, Yi Q, Ma J, Wang J, Zhuo J, Hu C |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/8cfb2087f7aa4e20b5bef4a44c0f4a04 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
by: Jiang KD, et al.
Published: (2017) -
Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
by: Xue-Qin Wang, et al.
Published: (2021) -
Effects of escitalopram with a Chinese traditional compound Jiuweizhenxin-keli on mismatch negativity and P50 in patients with major depressive disorders
by: Kuang W, et al.
Published: (2016) -
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
by: Kishi T, et al.
Published: (2017) -
Long-term administration of escitalopram in patients with social anxiety disorder in Japan
by: Asakura S, et al.
Published: (2016)